150 related articles for article (PubMed ID: 11094304)
41. The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.
Bahar AY; Taylor PJ; Andrews L; Proos A; Burnett L; Tucker K; Friedlander M; Buckley MF
Cancer; 2001 Jul; 92(2):440-5. PubMed ID: 11466700
[TBL] [Abstract][Full Text] [Related]
42. p53 and WAF1 polymorphisms in Jewish-Israeli women with epithelial ovarian cancer and its association with BRCA mutations.
Yair D; Ben Baruch G; Chetrit A; Friedman T; Hirsh Yechezkel G; Gotlieb WH; Fishman A; Beller U; Bar-Am A; Friedman E
BJOG; 2000 Jul; 107(7):849-54. PubMed ID: 10901555
[TBL] [Abstract][Full Text] [Related]
43. Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.
Dagan E; Gershoni-Baruch R; Kurolap A; Fried G
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27726213
[TBL] [Abstract][Full Text] [Related]
44. The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations.
Barnes-Kedar I; Bernstein-Molho R; Ginzach N; Hartmajer S; Shapira T; Magal N; Kalis ML; Peretz T; Shohat M; Basel-Salmon L; Friedman E; Bazak L; Goldberg Y
Breast Cancer Res Treat; 2018 Nov; 172(1):151-157. PubMed ID: 30014164
[TBL] [Abstract][Full Text] [Related]
45. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.
Ganguly A; Leahy K; Marshall AM; Dhulipala R; Godmilow L; Ganguly T
Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in Israel.
Ravid A; Barshack I; Hirsh-Yechezkel G; Goldberg I; Bar-Sade RB; Chetrit A; Reder I; Ben-Baruch G; Gotlieb WH; Kopolovic J; Friedman E
Eur J Cancer; 2000 Jun; 36(9):1120-4. PubMed ID: 10854945
[TBL] [Abstract][Full Text] [Related]
47. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
[TBL] [Abstract][Full Text] [Related]
48. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
[TBL] [Abstract][Full Text] [Related]
49. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
[TBL] [Abstract][Full Text] [Related]
50. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
[TBL] [Abstract][Full Text] [Related]
51. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
52. Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).
Modugno F; Moslehi R; Ness RB; Nelson DB; Belle S; Kant JA; Wheeler JE; Wonderlick A; Fishman D; Karlan B; Risch H; Cramer DW; Dube MP; Narod SA
Cancer Causes Control; 2003 Jun; 14(5):439-46. PubMed ID: 12946038
[TBL] [Abstract][Full Text] [Related]
53. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families.
Papp J; Raicevic L; Milasin J; Dimitrijevic B; Radulovic S; Olah E
Oncol Rep; 1999; 6(6):1435-8. PubMed ID: 10523726
[TBL] [Abstract][Full Text] [Related]
54. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.
Shih HA; Couch FJ; Nathanson KL; Blackwood MA; Rebbeck TR; Armstrong KA; Calzone K; Stopfer J; Seal S; Stratton MR; Weber BL
J Clin Oncol; 2002 Feb; 20(4):994-9. PubMed ID: 11844822
[TBL] [Abstract][Full Text] [Related]
55. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
[TBL] [Abstract][Full Text] [Related]
56. Cancer incidence in a population of Jewish women at risk of ovarian cancer.
Liede A; Karlan BY; Baldwin RL; Platt LD; Kuperstein G; Narod SA
J Clin Oncol; 2002 Mar; 20(6):1570-7. PubMed ID: 11896106
[TBL] [Abstract][Full Text] [Related]
57. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
Struewing JP; Abeliovich D; Peretz T; Avishai N; Kaback MM; Collins FS; Brody LC
Nat Genet; 1995 Oct; 11(2):198-200. PubMed ID: 7550349
[TBL] [Abstract][Full Text] [Related]
58. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.
Chen-Shtoyerman R; Figer A; Fidder HH; Rath P; Yeremin L; Bar Meir S; Friedman E; Theodor L
Br J Cancer; 2001 Feb; 84(4):475-7. PubMed ID: 11207040
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
[TBL] [Abstract][Full Text] [Related]
60. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
